Notal Vision Ltd announced that it will be completing the study of ForeseeHome by February 2010.
ForeseeHome is a home use monitoring device for the diagnosed Age-related Macular Degeneration (AMD) patients, for early detection of Choroidal Neovascularization CNV. It is designed for the early detection of CNV at home environment and device ease of use ensures patient’s increased test frequency, along with high sensitivity and accuracy. It is a automated, easy to use test, specifically designed for elderly people. It is functional test for AMD monitoring among mouse users. Its ease of use and sensitivity allows for higher frequency of test by patients, accurate results and earlier detection of a conversion, which enables quicker treatment and sight loss prevention.
The FORESEE HOME is used in the recent years to detect Age-related Macular Degeneration (AMD) lesions. The device is capable of differentiation as to stages of AMD and early detection of changes including choroidal neovascularization (CNV). The Foresee HOME demonstrates a high level of sensitivity and specificity as to the different stages of AMD including newly diagnosed or early detection of CNV.
The OCT may as well be used to identify choroidal neovascularization (CNV). Comparison between the two methods will allow better understanding of both devices. The FORESEE HOME can be used as an assessment tool for the progression and success of the treatment given to AMD lesions. Therefore, evaluation of the size and the location of the treated lesions may serve as an additional tool.